BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10697590)

  • 21. ETS transcription factors and their emerging roles in human cancer.
    Seth A; Watson DK
    Eur J Cancer; 2005 Nov; 41(16):2462-78. PubMed ID: 16213704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein p53--structure, function, and possible therapeutic implications.
    Batinac T; Gruber F; Lipozencić J; Zamolo-Koncar G; Stasić A; Brajac I
    Acta Dermatovenerol Croat; 2003 Dec; 11(4):225-30. PubMed ID: 14670223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of multistage carcinogenesis.
    Harris CC
    Princess Takamatsu Symp; 1991; 22():3-19. PubMed ID: 1844248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis and cancer mechanisms.
    Pan H; Yin C; Van Dyke T
    Cancer Surv; 1997; 29():305-27. PubMed ID: 9338106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The function of the p53 gene suppressor in carcinogenesis].
    Sándor J; Ambrus T; Ember I
    Orv Hetil; 1995 Aug; 136(35):1875-83. PubMed ID: 7675427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cancer genetics. A review of oncological molecular biology seen in relation to the human genome].
    Gerdes AM
    Ugeskr Laeger; 2002 May; 164(22):2865-71. PubMed ID: 12082811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Stat3 in regulating p53 expression and function.
    Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
    Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells.
    Ao L; Liu JY; Gao LH; Liu SX; Yang MS; Huang MH; Cao J
    Toxicol In Vitro; 2008 Feb; 22(1):116-27. PubMed ID: 17935941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.
    Kannan K; Kaminski N; Rechavi G; Jakob-Hirsch J; Amariglio N; Givol D
    Oncogene; 2001 Jun; 20(26):3449-55. PubMed ID: 11423996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular mechanisms of chemically induced carcinogenesis].
    Palut D; Kostka G; Adamczyk M
    Rocz Panstw Zakl Hig; 1998; 49(1):35-54. PubMed ID: 9734231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Generalities about carcinogenesis].
    Tubiana M
    C R Biol; 2008 Feb; 331(2):114-25. PubMed ID: 18241804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
    Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
    J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
    Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
    Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitivity of tumor cells. Oncogenes and apoptosis.
    Peltenburg LT
    Q J Nucl Med; 2000 Dec; 44(4):355-64. PubMed ID: 11302264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53--a natural cancer killer: structural insights and therapeutic concepts.
    Römer L; Klein C; Dehner A; Kessler H; Buchner J
    Angew Chem Int Ed Engl; 2006 Oct; 45(39):6440-60. PubMed ID: 16983711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.